nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Methoxsalen—psoriasis	0.0798	0.121	CbGbCtD
Bupropion—CYP2C8—Tazarotene—psoriasis	0.0611	0.0928	CbGbCtD
Bupropion—CYP1A2—Clobetasol propionate—psoriasis	0.058	0.0881	CbGbCtD
Bupropion—CYP2A6—Prednisolone—psoriasis	0.0388	0.059	CbGbCtD
Bupropion—CYP2B6—Cholecalciferol—psoriasis	0.0344	0.0523	CbGbCtD
Bupropion—CYP1A2—Methoxsalen—psoriasis	0.0305	0.0463	CbGbCtD
Bupropion—CYP2D6—Hydroxyurea—psoriasis	0.0274	0.0417	CbGbCtD
Bupropion—CYP2C8—Cholecalciferol—psoriasis	0.0261	0.0396	CbGbCtD
Bupropion—CYP2A6—Dexamethasone—psoriasis	0.0229	0.0348	CbGbCtD
Bupropion—CYP2C8—Mycophenolate mofetil—psoriasis	0.0226	0.0343	CbGbCtD
Bupropion—CYP3A4—Calcitriol—psoriasis	0.0205	0.0312	CbGbCtD
Bupropion—CYP2C9—Cholecalciferol—psoriasis	0.0182	0.0276	CbGbCtD
Bupropion—CYP2C8—Hydrocortisone—psoriasis	0.0181	0.0276	CbGbCtD
Bupropion—CYP2C8—Cyclosporine—psoriasis	0.0171	0.026	CbGbCtD
Bupropion—CYP2D6—Cholecalciferol—psoriasis	0.0166	0.0253	CbGbCtD
Bupropion—CYP3A4—Methoxsalen—psoriasis	0.016	0.0243	CbGbCtD
Bupropion—CYP2E1—Dexamethasone—psoriasis	0.0151	0.0229	CbGbCtD
Bupropion—CYP2B6—Dexamethasone—psoriasis	0.0149	0.0226	CbGbCtD
Bupropion—CYP2C9—Cyclosporine—psoriasis	0.0119	0.0182	CbGbCtD
Bupropion—CYP2C8—Dexamethasone—psoriasis	0.0113	0.0171	CbGbCtD
Bupropion—CYP2D6—Cyclosporine—psoriasis	0.0109	0.0166	CbGbCtD
Bupropion—CYP3A4—Cholecalciferol—psoriasis	0.0106	0.0161	CbGbCtD
Bupropion—CYP3A4—Mycophenolate mofetil—psoriasis	0.00917	0.0139	CbGbCtD
Bupropion—CYP3A4—Triamcinolone—psoriasis	0.00917	0.0139	CbGbCtD
Bupropion—CYP2C9—Dexamethasone—psoriasis	0.00787	0.012	CbGbCtD
Bupropion—CYP3A4—Betamethasone—psoriasis	0.00786	0.012	CbGbCtD
Bupropion—CYP3A4—Prednisolone—psoriasis	0.00776	0.0118	CbGbCtD
Bupropion—CYP3A4—Hydrocortisone—psoriasis	0.00736	0.0112	CbGbCtD
Bupropion—CYP3A4—Prednisone—psoriasis	0.00733	0.0111	CbGbCtD
Bupropion—CYP2D6—Dexamethasone—psoriasis	0.00719	0.0109	CbGbCtD
Bupropion—CYP3A4—Cyclosporine—psoriasis	0.00695	0.0106	CbGbCtD
Bupropion—CYP3A4—Dexamethasone—psoriasis	0.00457	0.00695	CbGbCtD
Bupropion—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00225	0.0624	CbGpPWpGaD
Bupropion—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00182	0.0503	CbGpPWpGaD
Bupropion—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00178	0.0493	CbGpPWpGaD
Bupropion—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00154	0.0426	CbGpPWpGaD
Bupropion—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00139	0.0387	CbGpPWpGaD
Bupropion—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00126	0.035	CbGpPWpGaD
Bupropion—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00125	0.0347	CbGpPWpGaD
Bupropion—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00118	0.0326	CbGpPWpGaD
Bupropion—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00113	0.0312	CbGpPWpGaD
Bupropion—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.0011	0.0306	CbGpPWpGaD
Bupropion—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000953	0.0264	CbGpPWpGaD
Bupropion—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000782	0.0217	CbGpPWpGaD
Bupropion—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000775	0.0215	CbGpPWpGaD
Bupropion—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000662	0.0184	CbGpPWpGaD
Bupropion—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000579	0.0161	CbGpPWpGaD
Bupropion—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000571	0.0158	CbGpPWpGaD
Bupropion—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000511	0.0142	CbGpPWpGaD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000469	0.013	CbGpPWpGaD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000467	0.013	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000461	0.0128	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000458	0.0127	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000452	0.0125	CbGpPWpGaD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000396	0.011	CbGpPWpGaD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00039	0.0108	CbGpPWpGaD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000379	0.0105	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000371	0.0103	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000363	0.0101	CbGpPWpGaD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000325	0.009	CbGpPWpGaD
Bupropion—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000322	0.00893	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000321	0.00889	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00032	0.00889	CbGpPWpGaD
Bupropion—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000318	0.00881	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000275	0.00763	CbGpPWpGaD
Bupropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000273	0.00756	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000271	0.00753	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000263	0.0073	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000261	0.00724	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000249	0.00691	CbGpPWpGaD
Bupropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000242	0.0067	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.00024	0.00666	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000231	0.00642	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000223	0.00618	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000215	0.00595	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000212	0.00589	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00021	0.00583	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.00021	0.00582	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00021	0.00581	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000201	0.00558	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000198	0.0055	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000197	0.00546	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000194	0.00539	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—TGFA—psoriasis	0.000188	0.0052	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000172	0.00477	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.00017	0.00472	CbGpPWpGaD
Bupropion—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.00017	0.00471	CbGpPWpGaD
Bupropion—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00017	0.00471	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000168	0.00466	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—TGFA—psoriasis	0.000166	0.00461	CbGpPWpGaD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—STAT3—psoriasis	0.000151	0.00417	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00015	0.00415	CbGpPWpGaD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000148	0.0041	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000147	0.00406	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.00014	0.00388	CbGpPWpGaD
Bupropion—SLC6A2—Monoamine Transport—TNF—psoriasis	0.00014	0.00387	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000139	0.00385	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000139	0.00384	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000138	0.00382	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000137	0.00379	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000136	0.00376	CbGpPWpGaD
Bupropion—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000135	0.00374	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000132	0.00366	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000126	0.0035	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000124	0.00344	CbGpPWpGaD
Bupropion—SLC6A3—Monoamine Transport—TNF—psoriasis	0.000124	0.00343	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000118	0.00328	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000117	0.00324	CbGpPWpGaD
Bupropion—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000117	0.00323	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000115	0.00318	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—CP—psoriasis	0.00011	0.00304	CbGpPWpGaD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000103	0.00286	CbGpPWpGaD
Bupropion—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000102	0.00283	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.75e-05	0.0027	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP2S1—psoriasis	9.14e-05	0.00253	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	9.02e-05	0.0025	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	8.89e-05	0.00247	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.81e-05	0.00244	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	8.06e-05	0.00224	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.89e-05	0.00219	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.83e-05	0.00189	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.8e-05	0.00189	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	6.3e-05	0.00175	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	6.01e-05	0.00167	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.68e-05	0.00157	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	5.58e-05	0.00155	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	5.32e-05	0.00148	CbGpPWpGaD
Bupropion—Dermatitis—Mycophenolic acid—psoriasis	5.31e-05	0.000174	CcSEcCtD
Bupropion—Pain—Prednisolone—psoriasis	5.31e-05	0.000174	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—psoriasis	5.31e-05	0.000174	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—psoriasis	5.31e-05	0.000174	CcSEcCtD
Bupropion—Urticaria—Mycophenolate mofetil—psoriasis	5.29e-05	0.000173	CcSEcCtD
Bupropion—Headache—Mycophenolic acid—psoriasis	5.28e-05	0.000173	CcSEcCtD
Bupropion—Decreased appetite—Hydrocortisone—psoriasis	5.27e-05	0.000172	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—psoriasis	5.27e-05	0.000172	CcSEcCtD
Bupropion—Abdominal pain—Mycophenolate mofetil—psoriasis	5.26e-05	0.000172	CcSEcCtD
Bupropion—Body temperature increased—Mycophenolate mofetil—psoriasis	5.26e-05	0.000172	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—psoriasis	5.24e-05	0.000171	CcSEcCtD
Bupropion—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.24e-05	0.000171	CcSEcCtD
Bupropion—Fatigue—Hydrocortisone—psoriasis	5.23e-05	0.000171	CcSEcCtD
Bupropion—Vision blurred—Prednisone—psoriasis	5.21e-05	0.00017	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—psoriasis	5.2e-05	0.00017	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.2e-05	0.00017	CcSEcCtD
Bupropion—Pain—Hydrocortisone—psoriasis	5.19e-05	0.00017	CcSEcCtD
Bupropion—Anaphylactic shock—Betamethasone—psoriasis	5.18e-05	0.000169	CcSEcCtD
Bupropion—Oedema—Betamethasone—psoriasis	5.18e-05	0.000169	CcSEcCtD
Bupropion—Anaphylactic shock—Dexamethasone—psoriasis	5.18e-05	0.000169	CcSEcCtD
Bupropion—Oedema—Dexamethasone—psoriasis	5.18e-05	0.000169	CcSEcCtD
Bupropion—Insomnia—Triamcinolone—psoriasis	5.16e-05	0.000169	CcSEcCtD
Bupropion—Infection—Dexamethasone—psoriasis	5.15e-05	0.000168	CcSEcCtD
Bupropion—Infection—Betamethasone—psoriasis	5.15e-05	0.000168	CcSEcCtD
Bupropion—Ill-defined disorder—Prednisone—psoriasis	5.13e-05	0.000168	CcSEcCtD
Bupropion—Paraesthesia—Triamcinolone—psoriasis	5.13e-05	0.000168	CcSEcCtD
Bupropion—Feeling abnormal—Prednisolone—psoriasis	5.12e-05	0.000167	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—psoriasis	5.11e-05	0.000167	CcSEcCtD
Bupropion—Anaemia—Prednisone—psoriasis	5.11e-05	0.000167	CcSEcCtD
Bupropion—Shock—Dexamethasone—psoriasis	5.1e-05	0.000167	CcSEcCtD
Bupropion—Shock—Betamethasone—psoriasis	5.1e-05	0.000167	CcSEcCtD
Bupropion—Dyspnoea—Triamcinolone—psoriasis	5.09e-05	0.000166	CcSEcCtD
Bupropion—Nervous system disorder—Dexamethasone—psoriasis	5.08e-05	0.000166	CcSEcCtD
Bupropion—Nervous system disorder—Betamethasone—psoriasis	5.08e-05	0.000166	CcSEcCtD
Bupropion—Agitation—Prednisone—psoriasis	5.08e-05	0.000166	CcSEcCtD
Bupropion—Thrombocytopenia—Betamethasone—psoriasis	5.07e-05	0.000166	CcSEcCtD
Bupropion—Thrombocytopenia—Dexamethasone—psoriasis	5.07e-05	0.000166	CcSEcCtD
Bupropion—Tachycardia—Dexamethasone—psoriasis	5.06e-05	0.000165	CcSEcCtD
Bupropion—Tachycardia—Betamethasone—psoriasis	5.06e-05	0.000165	CcSEcCtD
Bupropion—Angioedema—Prednisone—psoriasis	5.05e-05	0.000165	CcSEcCtD
Bupropion—Hypersensitivity—Cyclosporine—psoriasis	5.03e-05	0.000164	CcSEcCtD
Bupropion—Dyspepsia—Triamcinolone—psoriasis	5.03e-05	0.000164	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—psoriasis	5.02e-05	0.000164	CcSEcCtD
Bupropion—CYP2A6—Metabolism—NDUFA5—psoriasis	5.02e-05	0.00139	CbGpPWpGaD
Bupropion—Nausea—Mycophenolic acid—psoriasis	5.01e-05	0.000164	CcSEcCtD
Bupropion—Hyperhidrosis—Dexamethasone—psoriasis	5.01e-05	0.000164	CcSEcCtD
Bupropion—Hyperhidrosis—Betamethasone—psoriasis	5.01e-05	0.000164	CcSEcCtD
Bupropion—Feeling abnormal—Hydrocortisone—psoriasis	5e-05	0.000163	CcSEcCtD
Bupropion—Malaise—Prednisone—psoriasis	4.99e-05	0.000163	CcSEcCtD
Bupropion—Vertigo—Prednisone—psoriasis	4.97e-05	0.000162	CcSEcCtD
Bupropion—Eye disorder—Methotrexate—psoriasis	4.96e-05	0.000162	CcSEcCtD
Bupropion—Gastrointestinal pain—Hydrocortisone—psoriasis	4.96e-05	0.000162	CcSEcCtD
Bupropion—Syncope—Prednisone—psoriasis	4.96e-05	0.000162	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—psoriasis	4.95e-05	0.000162	CcSEcCtD
Bupropion—Anorexia—Betamethasone—psoriasis	4.94e-05	0.000161	CcSEcCtD
Bupropion—Anorexia—Dexamethasone—psoriasis	4.94e-05	0.000161	CcSEcCtD
Bupropion—Urticaria—Prednisolone—psoriasis	4.93e-05	0.000161	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—psoriasis	4.93e-05	0.000161	CcSEcCtD
Bupropion—Fatigue—Triamcinolone—psoriasis	4.92e-05	0.000161	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.91e-05	0.00136	CbGpPWpGaD
Bupropion—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.9e-05	0.00016	CcSEcCtD
Bupropion—Asthenia—Cyclosporine—psoriasis	4.9e-05	0.00016	CcSEcCtD
Bupropion—Pain—Triamcinolone—psoriasis	4.88e-05	0.00016	CcSEcCtD
Bupropion—Loss of consciousness—Prednisone—psoriasis	4.86e-05	0.000159	CcSEcCtD
Bupropion—Hypotension—Betamethasone—psoriasis	4.84e-05	0.000158	CcSEcCtD
Bupropion—Hypotension—Dexamethasone—psoriasis	4.84e-05	0.000158	CcSEcCtD
Bupropion—Pruritus—Cyclosporine—psoriasis	4.83e-05	0.000158	CcSEcCtD
Bupropion—Urticaria—Hydrocortisone—psoriasis	4.82e-05	0.000157	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—psoriasis	4.82e-05	0.000157	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—psoriasis	4.79e-05	0.000157	CcSEcCtD
Bupropion—Abdominal pain—Hydrocortisone—psoriasis	4.79e-05	0.000157	CcSEcCtD
Bupropion—Body temperature increased—Hydrocortisone—psoriasis	4.79e-05	0.000157	CcSEcCtD
Bupropion—Convulsion—Prednisone—psoriasis	4.79e-05	0.000157	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—psoriasis	4.78e-05	0.000156	CcSEcCtD
Bupropion—Asthenia—Mycophenolate mofetil—psoriasis	4.78e-05	0.000156	CcSEcCtD
Bupropion—Hypertension—Prednisone—psoriasis	4.77e-05	0.000156	CcSEcCtD
Bupropion—Chills—Methotrexate—psoriasis	4.76e-05	0.000156	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.72e-05	0.00131	CbGpPWpGaD
Bupropion—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.72e-05	0.000154	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Betamethasone—psoriasis	4.72e-05	0.000154	CcSEcCtD
Bupropion—Pruritus—Mycophenolate mofetil—psoriasis	4.71e-05	0.000154	CcSEcCtD
Bupropion—Arthralgia—Prednisone—psoriasis	4.71e-05	0.000154	CcSEcCtD
Bupropion—Myalgia—Prednisone—psoriasis	4.71e-05	0.000154	CcSEcCtD
Bupropion—Feeling abnormal—Triamcinolone—psoriasis	4.71e-05	0.000154	CcSEcCtD
Bupropion—Anxiety—Prednisone—psoriasis	4.69e-05	0.000153	CcSEcCtD
Bupropion—Alopecia—Methotrexate—psoriasis	4.69e-05	0.000153	CcSEcCtD
Bupropion—Insomnia—Betamethasone—psoriasis	4.69e-05	0.000153	CcSEcCtD
Bupropion—Insomnia—Dexamethasone—psoriasis	4.69e-05	0.000153	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.67e-05	0.000153	CcSEcCtD
Bupropion—Diarrhoea—Cyclosporine—psoriasis	4.67e-05	0.000153	CcSEcCtD
Bupropion—Paraesthesia—Betamethasone—psoriasis	4.65e-05	0.000152	CcSEcCtD
Bupropion—Paraesthesia—Dexamethasone—psoriasis	4.65e-05	0.000152	CcSEcCtD
Bupropion—Discomfort—Prednisone—psoriasis	4.65e-05	0.000152	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—psoriasis	4.65e-05	0.000152	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—psoriasis	4.62e-05	0.000151	CcSEcCtD
Bupropion—Hypersensitivity—Prednisolone—psoriasis	4.57e-05	0.00015	CcSEcCtD
Bupropion—Dyspepsia—Betamethasone—psoriasis	4.56e-05	0.000149	CcSEcCtD
Bupropion—Dyspepsia—Dexamethasone—psoriasis	4.56e-05	0.000149	CcSEcCtD
Bupropion—Diarrhoea—Mycophenolate mofetil—psoriasis	4.55e-05	0.000149	CcSEcCtD
Bupropion—Urticaria—Triamcinolone—psoriasis	4.54e-05	0.000148	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—psoriasis	4.52e-05	0.000148	CcSEcCtD
Bupropion—Body temperature increased—Triamcinolone—psoriasis	4.51e-05	0.000148	CcSEcCtD
Bupropion—Dizziness—Cyclosporine—psoriasis	4.51e-05	0.000148	CcSEcCtD
Bupropion—Anaphylactic shock—Prednisone—psoriasis	4.51e-05	0.000147	CcSEcCtD
Bupropion—Oedema—Prednisone—psoriasis	4.51e-05	0.000147	CcSEcCtD
Bupropion—Decreased appetite—Betamethasone—psoriasis	4.5e-05	0.000147	CcSEcCtD
Bupropion—Decreased appetite—Dexamethasone—psoriasis	4.5e-05	0.000147	CcSEcCtD
Bupropion—Infection—Prednisone—psoriasis	4.48e-05	0.000147	CcSEcCtD
Bupropion—Gastrointestinal disorder—Dexamethasone—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Gastrointestinal disorder—Betamethasone—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Back pain—Methotrexate—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Hypersensitivity—Hydrocortisone—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Fatigue—Betamethasone—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Fatigue—Dexamethasone—psoriasis	4.47e-05	0.000146	CcSEcCtD
Bupropion—Shock—Prednisone—psoriasis	4.44e-05	0.000145	CcSEcCtD
Bupropion—Pain—Betamethasone—psoriasis	4.43e-05	0.000145	CcSEcCtD
Bupropion—Pain—Dexamethasone—psoriasis	4.43e-05	0.000145	CcSEcCtD
Bupropion—Nervous system disorder—Prednisone—psoriasis	4.42e-05	0.000145	CcSEcCtD
Bupropion—Tachycardia—Prednisone—psoriasis	4.4e-05	0.000144	CcSEcCtD
Bupropion—Dizziness—Mycophenolate mofetil—psoriasis	4.4e-05	0.000144	CcSEcCtD
Bupropion—Skin disorder—Prednisone—psoriasis	4.38e-05	0.000143	CcSEcCtD
Bupropion—Hyperhidrosis—Prednisone—psoriasis	4.36e-05	0.000143	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—psoriasis	4.35e-05	0.000142	CcSEcCtD
Bupropion—Asthenia—Hydrocortisone—psoriasis	4.35e-05	0.000142	CcSEcCtD
Bupropion—Vomiting—Cyclosporine—psoriasis	4.34e-05	0.000142	CcSEcCtD
Bupropion—Rash—Cyclosporine—psoriasis	4.3e-05	0.000141	CcSEcCtD
Bupropion—Anorexia—Prednisone—psoriasis	4.3e-05	0.000141	CcSEcCtD
Bupropion—Dermatitis—Cyclosporine—psoriasis	4.3e-05	0.000141	CcSEcCtD
Bupropion—Pruritus—Hydrocortisone—psoriasis	4.29e-05	0.00014	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—psoriasis	4.29e-05	0.00014	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.29e-05	0.00119	CbGpPWpGaD
Bupropion—Headache—Cyclosporine—psoriasis	4.27e-05	0.00014	CcSEcCtD
Bupropion—Anaemia—Methotrexate—psoriasis	4.27e-05	0.00014	CcSEcCtD
Bupropion—Feeling abnormal—Betamethasone—psoriasis	4.27e-05	0.00014	CcSEcCtD
Bupropion—Feeling abnormal—Dexamethasone—psoriasis	4.27e-05	0.00014	CcSEcCtD
Bupropion—CYP2A6—Metabolism—CYP2S1—psoriasis	4.26e-05	0.00118	CbGpPWpGaD
Bupropion—Gastrointestinal pain—Dexamethasone—psoriasis	4.24e-05	0.000138	CcSEcCtD
Bupropion—Gastrointestinal pain—Betamethasone—psoriasis	4.24e-05	0.000138	CcSEcCtD
Bupropion—Vomiting—Mycophenolate mofetil—psoriasis	4.23e-05	0.000138	CcSEcCtD
Bupropion—Hypersensitivity—Triamcinolone—psoriasis	4.21e-05	0.000138	CcSEcCtD
Bupropion—Rash—Mycophenolate mofetil—psoriasis	4.2e-05	0.000137	CcSEcCtD
Bupropion—Dermatitis—Mycophenolate mofetil—psoriasis	4.19e-05	0.000137	CcSEcCtD
Bupropion—Headache—Mycophenolate mofetil—psoriasis	4.17e-05	0.000136	CcSEcCtD
Bupropion—Malaise—Methotrexate—psoriasis	4.17e-05	0.000136	CcSEcCtD
Bupropion—Vertigo—Methotrexate—psoriasis	4.15e-05	0.000136	CcSEcCtD
Bupropion—Diarrhoea—Hydrocortisone—psoriasis	4.15e-05	0.000136	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—psoriasis	4.14e-05	0.000135	CcSEcCtD
Bupropion—Urticaria—Dexamethasone—psoriasis	4.12e-05	0.000135	CcSEcCtD
Bupropion—Urticaria—Betamethasone—psoriasis	4.12e-05	0.000135	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Prednisone—psoriasis	4.11e-05	0.000134	CcSEcCtD
Bupropion—Dizziness—Prednisolone—psoriasis	4.11e-05	0.000134	CcSEcCtD
Bupropion—Asthenia—Triamcinolone—psoriasis	4.1e-05	0.000134	CcSEcCtD
Bupropion—Body temperature increased—Dexamethasone—psoriasis	4.1e-05	0.000134	CcSEcCtD
Bupropion—Abdominal pain—Betamethasone—psoriasis	4.1e-05	0.000134	CcSEcCtD
Bupropion—Body temperature increased—Betamethasone—psoriasis	4.1e-05	0.000134	CcSEcCtD
Bupropion—Abdominal pain—Dexamethasone—psoriasis	4.1e-05	0.000134	CcSEcCtD
Bupropion—Insomnia—Prednisone—psoriasis	4.08e-05	0.000133	CcSEcCtD
Bupropion—Nausea—Cyclosporine—psoriasis	4.05e-05	0.000132	CcSEcCtD
Bupropion—Paraesthesia—Prednisone—psoriasis	4.05e-05	0.000132	CcSEcCtD
Bupropion—CYP2B6—Metabolism—NDUFA5—psoriasis	4.05e-05	0.00112	CbGpPWpGaD
Bupropion—Pruritus—Triamcinolone—psoriasis	4.04e-05	0.000132	CcSEcCtD
Bupropion—Cough—Methotrexate—psoriasis	4.03e-05	0.000132	CcSEcCtD
Bupropion—Dizziness—Hydrocortisone—psoriasis	4.01e-05	0.000131	CcSEcCtD
Bupropion—Convulsion—Methotrexate—psoriasis	4e-05	0.000131	CcSEcCtD
Bupropion—Dyspepsia—Prednisone—psoriasis	3.97e-05	0.00013	CcSEcCtD
Bupropion—CYP2E1—Metabolism—NDUFA5—psoriasis	3.96e-05	0.0011	CbGpPWpGaD
Bupropion—Nausea—Mycophenolate mofetil—psoriasis	3.95e-05	0.000129	CcSEcCtD
Bupropion—Myalgia—Methotrexate—psoriasis	3.93e-05	0.000129	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—psoriasis	3.93e-05	0.000129	CcSEcCtD
Bupropion—Chest pain—Methotrexate—psoriasis	3.93e-05	0.000129	CcSEcCtD
Bupropion—Decreased appetite—Prednisone—psoriasis	3.92e-05	0.000128	CcSEcCtD
Bupropion—Rash—Prednisolone—psoriasis	3.91e-05	0.000128	CcSEcCtD
Bupropion—Dermatitis—Prednisolone—psoriasis	3.91e-05	0.000128	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.91e-05	0.000128	CcSEcCtD
Bupropion—Fatigue—Prednisone—psoriasis	3.89e-05	0.000127	CcSEcCtD
Bupropion—Headache—Prednisolone—psoriasis	3.89e-05	0.000127	CcSEcCtD
Bupropion—Discomfort—Methotrexate—psoriasis	3.89e-05	0.000127	CcSEcCtD
Bupropion—Constipation—Prednisone—psoriasis	3.86e-05	0.000126	CcSEcCtD
Bupropion—Vomiting—Hydrocortisone—psoriasis	3.86e-05	0.000126	CcSEcCtD
Bupropion—Rash—Hydrocortisone—psoriasis	3.82e-05	0.000125	CcSEcCtD
Bupropion—Dermatitis—Hydrocortisone—psoriasis	3.82e-05	0.000125	CcSEcCtD
Bupropion—Confusional state—Methotrexate—psoriasis	3.8e-05	0.000124	CcSEcCtD
Bupropion—Headache—Hydrocortisone—psoriasis	3.8e-05	0.000124	CcSEcCtD
Bupropion—Dizziness—Triamcinolone—psoriasis	3.78e-05	0.000123	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—psoriasis	3.77e-05	0.000123	CcSEcCtD
Bupropion—Infection—Methotrexate—psoriasis	3.75e-05	0.000122	CcSEcCtD
Bupropion—Feeling abnormal—Prednisone—psoriasis	3.72e-05	0.000122	CcSEcCtD
Bupropion—Asthenia—Dexamethasone—psoriasis	3.72e-05	0.000122	CcSEcCtD
Bupropion—Asthenia—Betamethasone—psoriasis	3.72e-05	0.000122	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—psoriasis	3.7e-05	0.000121	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—psoriasis	3.69e-05	0.000121	CcSEcCtD
Bupropion—Gastrointestinal pain—Prednisone—psoriasis	3.69e-05	0.000121	CcSEcCtD
Bupropion—Nausea—Prednisolone—psoriasis	3.69e-05	0.000121	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.67e-05	0.00102	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.67e-05	0.00102	CbGpPWpGaD
Bupropion—Pruritus—Dexamethasone—psoriasis	3.67e-05	0.00012	CcSEcCtD
Bupropion—Pruritus—Betamethasone—psoriasis	3.67e-05	0.00012	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—psoriasis	3.66e-05	0.00012	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—psoriasis	3.65e-05	0.000119	CcSEcCtD
Bupropion—Vomiting—Triamcinolone—psoriasis	3.63e-05	0.000119	CcSEcCtD
Bupropion—Nausea—Hydrocortisone—psoriasis	3.6e-05	0.000118	CcSEcCtD
Bupropion—Rash—Triamcinolone—psoriasis	3.6e-05	0.000118	CcSEcCtD
Bupropion—Dermatitis—Triamcinolone—psoriasis	3.6e-05	0.000118	CcSEcCtD
Bupropion—Anorexia—Methotrexate—psoriasis	3.59e-05	0.000117	CcSEcCtD
Bupropion—Urticaria—Prednisone—psoriasis	3.58e-05	0.000117	CcSEcCtD
Bupropion—Headache—Triamcinolone—psoriasis	3.58e-05	0.000117	CcSEcCtD
Bupropion—Abdominal pain—Prednisone—psoriasis	3.57e-05	0.000117	CcSEcCtD
Bupropion—Body temperature increased—Prednisone—psoriasis	3.57e-05	0.000117	CcSEcCtD
Bupropion—Diarrhoea—Dexamethasone—psoriasis	3.54e-05	0.000116	CcSEcCtD
Bupropion—Diarrhoea—Betamethasone—psoriasis	3.54e-05	0.000116	CcSEcCtD
Bupropion—Hypotension—Methotrexate—psoriasis	3.52e-05	0.000115	CcSEcCtD
Bupropion—CYP2B6—Metabolism—CYP2S1—psoriasis	3.44e-05	0.000954	CbGpPWpGaD
Bupropion—Musculoskeletal discomfort—Methotrexate—psoriasis	3.44e-05	0.000112	CcSEcCtD
Bupropion—Dizziness—Betamethasone—psoriasis	3.43e-05	0.000112	CcSEcCtD
Bupropion—Dizziness—Dexamethasone—psoriasis	3.43e-05	0.000112	CcSEcCtD
Bupropion—CYP2C8—Metabolism—NDUFA5—psoriasis	3.43e-05	0.00095	CbGpPWpGaD
Bupropion—Insomnia—Methotrexate—psoriasis	3.41e-05	0.000111	CcSEcCtD
Bupropion—Nausea—Triamcinolone—psoriasis	3.39e-05	0.000111	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—psoriasis	3.39e-05	0.000111	CcSEcCtD
Bupropion—CYP2E1—Metabolism—CYP2S1—psoriasis	3.37e-05	0.000934	CbGpPWpGaD
Bupropion—Dyspnoea—Methotrexate—psoriasis	3.36e-05	0.00011	CcSEcCtD
Bupropion—Somnolence—Methotrexate—psoriasis	3.35e-05	0.00011	CcSEcCtD
Bupropion—Hypersensitivity—Prednisone—psoriasis	3.32e-05	0.000109	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—psoriasis	3.32e-05	0.000109	CcSEcCtD
Bupropion—Vomiting—Betamethasone—psoriasis	3.29e-05	0.000108	CcSEcCtD
Bupropion—Vomiting—Dexamethasone—psoriasis	3.29e-05	0.000108	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—psoriasis	3.28e-05	0.000107	CcSEcCtD
Bupropion—Rash—Dexamethasone—psoriasis	3.27e-05	0.000107	CcSEcCtD
Bupropion—Rash—Betamethasone—psoriasis	3.27e-05	0.000107	CcSEcCtD
Bupropion—Dermatitis—Betamethasone—psoriasis	3.26e-05	0.000107	CcSEcCtD
Bupropion—Dermatitis—Dexamethasone—psoriasis	3.26e-05	0.000107	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—psoriasis	3.26e-05	0.000106	CcSEcCtD
Bupropion—Fatigue—Methotrexate—psoriasis	3.25e-05	0.000106	CcSEcCtD
Bupropion—Headache—Dexamethasone—psoriasis	3.25e-05	0.000106	CcSEcCtD
Bupropion—Headache—Betamethasone—psoriasis	3.25e-05	0.000106	CcSEcCtD
Bupropion—Asthenia—Prednisone—psoriasis	3.24e-05	0.000106	CcSEcCtD
Bupropion—Pain—Methotrexate—psoriasis	3.22e-05	0.000105	CcSEcCtD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.19e-05	0.000886	CbGpPWpGaD
Bupropion—Pruritus—Prednisone—psoriasis	3.19e-05	0.000104	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—psoriasis	3.11e-05	0.000102	CcSEcCtD
Bupropion—Diarrhoea—Prednisone—psoriasis	3.09e-05	0.000101	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—psoriasis	3.08e-05	0.000101	CcSEcCtD
Bupropion—Nausea—Dexamethasone—psoriasis	3.08e-05	0.000101	CcSEcCtD
Bupropion—Nausea—Betamethasone—psoriasis	3.08e-05	0.000101	CcSEcCtD
Bupropion—Urticaria—Methotrexate—psoriasis	3e-05	9.79e-05	CcSEcCtD
Bupropion—Dizziness—Prednisone—psoriasis	2.98e-05	9.75e-05	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—psoriasis	2.98e-05	9.74e-05	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—psoriasis	2.98e-05	9.74e-05	CcSEcCtD
Bupropion—CYP2C8—Metabolism—CYP2S1—psoriasis	2.91e-05	0.000808	CbGpPWpGaD
Bupropion—Vomiting—Prednisone—psoriasis	2.87e-05	9.38e-05	CcSEcCtD
Bupropion—Rash—Prednisone—psoriasis	2.84e-05	9.3e-05	CcSEcCtD
Bupropion—Dermatitis—Prednisone—psoriasis	2.84e-05	9.29e-05	CcSEcCtD
Bupropion—Headache—Prednisone—psoriasis	2.83e-05	9.24e-05	CcSEcCtD
Bupropion—CYP2D6—Metabolism—NDUFA5—psoriasis	2.81e-05	0.00078	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NDUFA5—psoriasis	2.79e-05	0.000773	CbGpPWpGaD
Bupropion—Hypersensitivity—Methotrexate—psoriasis	2.78e-05	9.08e-05	CcSEcCtD
Bupropion—Asthenia—Methotrexate—psoriasis	2.71e-05	8.84e-05	CcSEcCtD
Bupropion—Nausea—Prednisone—psoriasis	2.68e-05	8.76e-05	CcSEcCtD
Bupropion—Pruritus—Methotrexate—psoriasis	2.67e-05	8.72e-05	CcSEcCtD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.6e-05	0.000721	CbGpPWpGaD
Bupropion—Diarrhoea—Methotrexate—psoriasis	2.58e-05	8.43e-05	CcSEcCtD
Bupropion—Dizziness—Methotrexate—psoriasis	2.49e-05	8.15e-05	CcSEcCtD
Bupropion—Vomiting—Methotrexate—psoriasis	2.4e-05	7.84e-05	CcSEcCtD
Bupropion—CYP2D6—Metabolism—CYP2S1—psoriasis	2.39e-05	0.000663	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NDUFA5—psoriasis	2.38e-05	0.000661	CbGpPWpGaD
Bupropion—Rash—Methotrexate—psoriasis	2.38e-05	7.77e-05	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—psoriasis	2.38e-05	7.76e-05	CcSEcCtD
Bupropion—CYP2C9—Metabolism—CYP2S1—psoriasis	2.37e-05	0.000657	CbGpPWpGaD
Bupropion—Headache—Methotrexate—psoriasis	2.36e-05	7.72e-05	CcSEcCtD
Bupropion—Nausea—Methotrexate—psoriasis	2.24e-05	7.32e-05	CcSEcCtD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.22e-05	0.000616	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CARM1—psoriasis	2.08e-05	0.000577	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP2S1—psoriasis	2.03e-05	0.000562	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NDUFA5—psoriasis	1.84e-05	0.00051	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CARM1—psoriasis	1.68e-05	0.000466	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CARM1—psoriasis	1.65e-05	0.000456	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP2S1—psoriasis	1.56e-05	0.000434	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.53e-05	0.000423	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CARM1—psoriasis	1.42e-05	0.000394	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.33e-05	0.000369	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CAT—psoriasis	1.28e-05	0.000355	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.24e-05	0.000344	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CARM1—psoriasis	1.17e-05	0.000324	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CARM1—psoriasis	1.16e-05	0.000321	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.08e-05	0.0003	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.06e-05	0.000294	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CAT—psoriasis	1.03e-05	0.000287	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CAT—psoriasis	1.01e-05	0.000281	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—APOE—psoriasis	9.95e-06	0.000276	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CARM1—psoriasis	9.89e-06	0.000274	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.25e-06	0.000256	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CAT—psoriasis	8.75e-06	0.000243	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PPARG—psoriasis	8.67e-06	0.00024	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—APOE—psoriasis	8.03e-06	0.000223	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—APOE—psoriasis	7.87e-06	0.000218	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CARM1—psoriasis	7.64e-06	0.000212	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CAT—psoriasis	7.18e-06	0.000199	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CAT—psoriasis	7.12e-06	0.000197	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PPARG—psoriasis	6.99e-06	0.000194	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PPARG—psoriasis	6.85e-06	0.00019	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—APOE—psoriasis	6.8e-06	0.000188	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CAT—psoriasis	6.09e-06	0.000169	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PPARG—psoriasis	5.92e-06	0.000164	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—APOE—psoriasis	5.58e-06	0.000155	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—APOE—psoriasis	5.53e-06	0.000153	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PPARG—psoriasis	4.86e-06	0.000135	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PPARG—psoriasis	4.82e-06	0.000134	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—APOE—psoriasis	4.73e-06	0.000131	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CAT—psoriasis	4.7e-06	0.00013	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PPARG—psoriasis	4.12e-06	0.000114	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—APOE—psoriasis	3.65e-06	0.000101	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PPARG—psoriasis	3.18e-06	8.81e-05	CbGpPWpGaD
